Novozymatic: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Novozymatic
Largest movements
- Cash -€58,298
down €58,298 (-68.7%), from €84,891 to €26,593
mainly Net result for the year (-€98,442) and Short-term financial debts (-€740)
- Intangible fixed assets -€41,447
down €41,447 (-25.6%), from €161,664 to €120,216
- Profit (loss) carried forward -€98,442
down €98,442 (-17.8%), from -€553,804 to -€652,246
- Gross operating margin +€20,472
up €20,472 (+26.9%), from -€76,033 to -€55,561
- Depreciation +€7,993
up €7,993 (+23.6%), from €33,930 to €41,922
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €247,578 | €148,440 | -€99,137 | -40.0% |
| Fixed assets | 21/28 | €162,211 | €121,011 | -€41,200 | -25.4% |
| Intangible fixed assets | 21 | €161,664 | €120,216 | -€41,447 | -25.6% |
| Tangible fixed assets | 22/27 | €547 | €794 | +€247 | +45.2% |
| Furniture and vehicles | 24 | €547 | €794 | +€247 | +45.2% |
| Current assets | 29/58 | €85,367 | €27,430 | -€57,937 | -67.9% |
| Amounts receivable within one year | 40/41 | €476 | €837 | +€361 | +75.9% |
| Other amounts receivable | 41 | €476 | €837 | +€361 | +75.9% |
| Cash at bank and in hand | 54/58 | €84,891 | €26,593 | -€58,298 | -68.7% |
| Total equity and liabilities | 10/49 | €247,578 | €148,440 | -€99,137 | -40.0% |
| Equity | 10/15 | -€253,804 | -€352,246 | -€98,442 | -38.8% |
| Contributions | 10/11 | €300,000 | €300,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€553,804 | -€652,246 | -€98,442 | -17.8% |
| Amounts payable | 17/49 | €501,381 | €500,686 | -€695 | -0.1% |
| Amounts payable after more than one year | 17 | €500,000 | €500,000 | = | 0.0% |
| Other amounts payable | 178/9 | €500,000 | €500,000 | = | 0.0% |
| Amounts payable within one year | 42/48 | €1,381 | €686 | -€695 | -50.3% |
| Financial debts | 43 | €827 | €87 | -€740 | -89.5% |
| Credit institutions | 430/8 | €827 | €87 | -€740 | -89.5% |
| Trade debts | 44 | €554 | €599 | +€45 | +8.1% |
| Suppliers | 440/4 | €554 | €599 | +€45 | +8.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €33,930 | €41,922 | +€7,993 | +23.6% |
| Other operating charges | 640/8 | €505 | €724 | +€218 | +43.2% |
| Gross operating margin | 9900 | -€76,033 | -€55,561 | +€20,472 | +26.9% |
| Operating profit (loss) | 9901 | -€110,468 | -€98,207 | +€12,261 | +11.1% |
| Financial income | 75/76B | €0 | - | = | |
| Recurring financial income | 75 | €0 | - | = | |
| Financial charges | 65/66B | €514 | €235 | -€279 | -54.3% |
| Recurring financial charges | 65 | €514 | €235 | -€279 | -54.3% |
| Profit (loss) for the period before taxes | 9903 | -€110,982 | -€98,442 | +€12,540 | +11.3% |
| Profit (loss) for the period | 9904 | -€110,982 | -€98,442 | +€12,540 | +11.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€110,982 | -€98,442 | +€12,540 | +11.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.